Table 1.
Patients characteristics.
| Gender | N | % | Extension of resection | N | % | |
|---|---|---|---|---|---|---|
| Male | 65 | 61.9 | Complete | 42 | 38.9 | |
| Female | 40 | 38.1 | >90% | 28 | 25.9 | |
| <90% | 7 | 6.5 | ||||
| Age at surgery (y) | Mean | SD | Biopsy | 15 | 13.9 | |
| 49.6 | 12.8 | n.a. | 16 | 14.8 | ||
| Diagnosis (WHO 2021) | Grade | N | % | Karnofsky index (%)* | N | % |
| Glioblastoma IDH wt | 4 | 87 | 82.9 | 100 | 5 | 4.8 |
| Astrocyotoma IDH mut | 4 | 7 | 6.6 | 90 | 63 | 60 |
| Astrocyotoma IDH mut | 3 | 3 | 2.9 | 80 | 20 | 19 |
| n.a. | 4 | 8 | 7.6 | 70 | 4 | 3.8 |
| 60 | 4 | 3.8 | ||||
| MGMT | N | % | n.a. | 9 | 8.6 | |
| Unmethylated | 50 | 47.6 | ||||
| Methylated | 39 | 37.1 | ||||
| n.a. | 16 | 15.2 | ||||
N, number of patients; %, percentage of the analyzed cohort; SD, standard deviation; IDH, isocitrate dehydrogenase; wt, wild-type, mut, mutant; n.a., not available; *preoperative.